First patient dosed in IPH5201 Phase I clinical trial in advanced solid tumors

NEXT STORY
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
PREV STORY
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award

author_avatar
NASDAQ Market News

POINT Biopharma Adds Senior BD Expertise with Appointment of Dr. Matthew Vincent as SVP, Business Development

author_avatar
NASDAQ Market News

Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

author_avatar
NASDAQ Market News